As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (Senior Housing - Leased), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 …
Over the last 12 months, insiders at Sabra Health Care REIT, Inc. have bought $101,010 and sold $146,830 worth of Sabra Health Care REIT, Inc. stock.
On average, over the past 5 years, insiders at Sabra Health Care REIT, Inc. have bought $90,876 and sold $558,725 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Cusack Catherine (director) — $101,010.
The last purchase of 7,000 shares for transaction amount of $101,010 was made by Cusack Catherine (director) on 2024‑05‑22.
2024-05-22 | director | 7,000 0.003% | $14.43 | $101,010 | +21.30% | |||
2024-05-14 | Sale | director | 10,000 0.0043% | $14.68 | $146,830 | +17.77% | ||
2023-09-01 | Executive VP, CFO & Secretary | 1,947 0.0008% | $12.63 | $24,591 | +9.55% | |||
2022-02-25 | director | 2,000 0.0009% | $13.24 | $26,480 | +4.11% | |||
2021-12-29 | Sale | Executive VP, CFO & Secretary | 110,000 0.0503% | $13.55 | $1.49M | +4.31% | ||
2021-05-13 | director | 4,000 0.0019% | $17.19 | $68,760 | -10.84% | |||
2021-03-04 | Sale | director | 12,000 0.0056% | $17.46 | $209,490 | -5.93% | ||
2021-03-02 | director | 2,000 0.001% | $17.34 | $34,680 | -3.32% | |||
2020-03-16 | director | 25,750 0.013% | $7.72 | $198,858 | +106.77% | |||
2020-03-06 | Sale | director | 21,090 0.0101% | $18.39 | $387,837 | -18.16% | ||
2019-11-04 | Sale | Chairman, CEO and President | 113,000 0.0573% | $24.05 | $2.72M | -33.05% | ||
2019-08-26 | Sale | director | 58,000 0.0304% | $21.47 | $1.25M | -2.39% | ||
2019-08-14 | Sale | director | 15,000 0.0078% | $20.78 | $311,700 | +4.28% | ||
2018-03-22 | Sale | Executive VP, CFO & Secretary | 600 0.0003% | $17.36 | $10,416 | +24.77% | ||
2017-11-30 | Sale | director | 4,615 0.0044% | $19.18 | $88,513 | +9.57% | ||
2016-06-06 | Sale | director | 2,000 0.0031% | $22.04 | $44,080 | +14.54% | ||
2015-12-08 | director | 5,000 0.0077% | $19.86 | $99,291 | +11.00% | |||
2015-11-13 | Sale | director | 2,500 0.0039% | $19.75 | $49,375 | +15.14% | ||
2015-11-13 | director | 2,500 0.004% | $19.80 | $49,500 | +15.14% | |||
2015-11-12 | Executive VP, CFO & Secretary | 6,600 0.0098% | $19.07 | $125,867 | +11.89% |
FOSTER MICHAEL J | director | 63923 0.027% | $17.07 | 6 | 3 | +35.86% |
Cusack Catherine | director | 46385 0.0196% | $17.07 | 4 | 0 | <0.0001% |
MATROS RICHARD K | Chairman, CEO and President | 959989 0.4058% | $17.07 | 2 | 1 | +29.45% |
Andrews Harold W. Jr. | Executive VP, CFO & Secretary | 474693 0.2006% | $17.07 | 3 | 2 | +23.32% |
Costa Michael Lourenco | Executive VP, CFO & Secretary | 183218 0.0774% | $17.07 | 1 | 0 |
The Vanguard Group | $516.55M | 15.11 | 34.97M | +2.46% | +$12.39M | 0.01 | |
BlackRock | $505.11M | 14.77 | 34.2M | -0.78% | -$3.99M | 0.01 | |
State Street | $172.95M | 5.06 | 11.71M | -6.32% | -$11.66M | 0.01 | |
JPMorgan Chase | $151.67M | 4.44 | 10.27M | +53.08% | +$52.59M | 0.01 | |
Geode Capital Management | $87.78M | 2.57 | 5.94M | +2.84% | +$2.42M | 0.01 |